Reveals notable antioxidant and enzyme inhibitory properties in Onosma serpentinica extracts, suggesting a promising source of bioactive metabolites.
Newly described endemic Onosma species adapted to serpentine habitats may represent promising sources of bioactive metabolites; however, the phytochemical and biological properties of Onosma serpentinica remain unknown. This study investigated the phytochemical composition and biological activities of O. serpentinica extracts obtained by ultrasound-assisted extraction using ethyl acetate, methanol, and water. Total phenolic and flavonoid contents were determined spectrophotometrically, while phenolic compounds were characterized using validated liquid chromatography–electrospray ionization tandem mass spectrometry (LC–ESI–MS/MS) analysis. Antioxidant capacity was evaluated using multiple in vitro assays, and enzyme inhibitory activities were assessed against cholinesterases, tyrosinase, α-amylase, and α-glucosidase. The methanol extract exhibited the highest total phenolic (69.93 mg gallic acid equivalents/g extract) and flavonoid contents (38.32 mg rutin equivalents/g extract) and was particularly rich in rosmarinic acid (5840 µg/g extract), chlorogenic acid (1115 µg/g extract), and apigenin-7-glucoside (977 µg/g extract). It also showed the strongest antioxidant activity, with the lowest half maximal inhibitory concentration (IC50) values in 2,2-diphenyl-1-picrylhydrazyl (DPPH) (0.80 mg/mL) and 2,2′-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) (0.58 mg/mL) assays and the highest relative antioxidant capacity index (RACI). The aqueous extract exhibited the strongest metal chelating activity (IC50: 1.14 mg/mL), whereas the ethyl acetate extract showed the highest α-amylase inhibition (IC50: 1.34 mg/mL). Overall, O. serpentinica represents a promising source of phenolic compounds with notable antioxidant and enzyme inhibitory properties. This study provides the first comprehensive report on the phenolic composition and bioactivity of O. serpentinica.
No takes yet. Share an insight, caveat, or question.
Kırkan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: